Cas:655253-57-9 (3-methyl-5-phenylimidazol-4-yl)methanol manufacturer & supplier

Chemical Name:(3-methyl-5-phenylimidazol-4-yl)methanol

CAS.NO:655253-57-9

Synonyms:(1-methyl-4-phenyl-1H-imidazol-5-yl)methanol;1H-Imidazole-5-methanol,1-methyl-4-phenyl

Molecular Formula:C₁₁H₁₂N₂O

Molecular Weight:188.22600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:38.05000

Exact Mass:188.09500

LogP:1.57940

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1-methyl-4-phenyl-1H-imidazol-5-yl)methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Imidazole-5-methanol,1-methyl-4-phenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1-methyl-4-phenyl-1H-imidazol-5-yl)methanol Use and application,(1-methyl-4-phenyl-1H-imidazol-5-yl)methanol technical grade,usp/ep/jp grade.

Related News: Government prosecutors often consider whether a corporation made a genuine effort to investigate and address potentially illegal activities once learning of them. (3-methyl-5-phenylimidazol-4-yl)methanol manufacturer Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. (3-methyl-5-phenylimidazol-4-yl)methanol supplier Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. (3-methyl-5-phenylimidazol-4-yl)methanol vendor When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. (3-methyl-5-phenylimidazol-4-yl)methanol factory The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.